News
As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...
Tana Mongeau has warned people against using Mounjaro for weight loss, after experiencing crippling side effects on the ...
Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...
All the health conditions weight-loss drugs are being used and tested for - Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some succe ...
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
2h
Zacks Investment Research on MSNShould You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?
Eli Lilly and Company LLY will report its second-quarter earnings on Aug. 7, before market open. The Zacks Consensus Estimate ...
The risk for major adverse cardiovascular events decreased with tirzepatide vs. liraglutide and semaglutide in patients with ...
Novo Nordisk is misunderstood by the market, creating a rare asymmetric value opportunity. Read why I rate NVO stock a Buy ...
A hormone expert has explained why some people’s sex drive goes ‘through the roof’ while using Mounjaro. Use of the drug for ...
Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results